Thus we propose that in pancreatic cancer cells there is a loss of interaction between Nrf2 and KEAP1 on exposure to esculetin that ultimately depletes ROS and abrogate NF-κB activity. The gene discussed is NFKB1; the disease is pancreatic neoplasm.